Kapitalisasi marang bathi Haleon Corp (HLN)

Haleon plc demonstrates high resilience to macroeconomic shocks due to stable demand for hygiene products. The company's forward P/E clearly illustrates the dynamics of market valuation relative to earnings, where 18.60 represents the current level of the metric. Growth is driven by the expansion of global mega-brands into new markets, while efficiency is maintained through the automation of packaging lines at its plants.

HLN: Pangali P/E haleon.com 28.04.2023 - 15.11.2026

Rincian analitis perusahaan Haleon plc

- rega saham lan prakiraan rega para ahli:

Bagan owah-owahan rega Haleon PLC|HLN - Bagan rega target

- rincian kapitalisasi pasar:

Nilai pasar Haleon Corp|HLN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator nilai buku ekuitas:

Rega Buku Saham Haleon|HLN - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku haleon.com|HLN - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- informasi bathi lan kelipatan valuasi:

HLN - Bathi resik|Bathi resik sing dikarepake Haleon plc|HLN - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Haleon Corp|HLN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Haleon Corp|HLN - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Haleon|HLN - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan haleon.com|HLN - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Haleon plc

- statistik dodolan lan pendapatan perusahaan:

HLN - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Haleon|HLN - Multiplikator P/S|Rega forward marang dodolan Haleon Group|HLN - Wutah dodolan YoY sajrone rolas wulan kepungkur

Ringkesan analisis perusahaan:Haleon - HLN

Haleon plc (HLN) creates high business added value through its innovative approach to developing safe hygiene products. The P/E ratio reflects this efficiency by relating the current market share price to the net earnings per share. This metric determines the investment payback period and the extent of the premium paid for future growth. By analyzing the P/E volatility of Haleon plc (HLN), an investor can timely identify phases of asset overvaluation or undervaluation.

Pesaing wigati

Pangali P/E Kenvue Corp|Koefisien rega marang bathi VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Kapitalisasi marang bathi|PRGO: Koefisien rega marang bathi|Alvotech SA - Rasio rega pasar marang bathi resik|LQDA: Pangali P/E|Galapagos Genomics - Nilai perusahaan marang bathi resik|ANIP (ANI Pharmaceuticals Inc) - Pangali P/E|Kapitalisasi marang bathi mannkindcorp.com MNKD|Rasio rega marang bathi Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Nilai perusahaan marang bathi resik|Pangali P/E SPRY (ARS Pharmaceuticals Inc)|Rasio rega pasar marang bathi resik TBPH (Theravance)|AQST - Rasio rega marang bathi|scPharmaceuticals (SCPH) - Koefisien rega marang bathi|TECX: Pangali P/E|Pangali rega marang bathi TNXP|Rasio rega marang bathi China SXT Pharmaceuticals, Inc.|EPRX: Nilai perusahaan marang bathi resik|Pangali P/E BHST|EXOZ - Kapitalisasi marang bathi|Pangali P/E ORMP (oramed.com)|Pangali P/E enterabio.com ENTX|HYFT - Rasio rega marang bathi|Periode bali modal bisnis ABVC BioPharma, Inc ABVC|CPIX: Pangali P/E|Quantum BioPharma Ltd - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi FGEN|Telomir Pharmaceuticals, Inc. - Kapitalisasi marang bathi resik|Pangali P/E RANI|SNYR (Synergy CHC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalisasi marang bathi|PULM - Rasio rega marang bathi|Periode bali modal bisnis Pheton Holdings PTHL|APM (Aptorum) - Koefisien rega marang bathi|Lyra Therapeutics, Inc. (LYRA) - Pangali P/E|IBO (impactbiomedinc.com) - Pangali P/E|TNFA (TNF Pharmaceuticals) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi cbdmd.com (YCBD)|Periode bali modal bisnis PainReform Ltd|Pangali P/E CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalisasi marang bathi|OPTN - Rasio rega marang bathi|Pieris Pharmaceuticals - Rasio rega pasar marang bathi resik|PROC (Procaps Group) - Koefisien rega marang bathi|PTPI - Periode bali modal bisnis|Rasio rega marang bathi Qilian International Holding Group Limited|SLRN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TFFP (TFF Pharma)